DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Hyman D, Kummar S, Farago A. et al.
CT-127 – phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi).
In:
Proceedings of the 10th Annual Meeting of the American Association for Cancer Research; 2019.
Philadelphia PA: AACR; 2019: 127
We do not assume any responsibility for the contents of the web pages of other providers.